Background: Stereotactic treatment approaches lead to a significant reduction of irradiated volumes, which should make pulmonary targets more accessible to radiotherapy.
Patients And Methods: Between May 1997 and December 2005, 61 patients received stereotactic single-dose dose treatment for 71 pulmonary metastases. Doses to the isocenter ranged from 12 to 30 Gy. Survival and local tumor control rates were evaluated prospectively.
Results: After a median follow-up period of 14 months the actuarial overall survival was 78.4%, 65.1%, and 47.8% 12, 24, and 36 months after therapy, respectively. There was a significantly better survival (p = 0.023) for patients not developing further metastases during follow-up. The actuarial local progression-free rate was 88.6%, 73.7%, and 63.1% 12, 24, and 36 months after therapy. Although the majority of patients (70.4%) developed perifocal normal-tissue changes, these were not related to clinically relevant toxicities.
Conclusion: Stereotactic single-dose radiotherapy is a feasible, safe and effective local treatment option for solitary pulmonary metastases in patients with contraindications to surgery or for palliation of symptomatic pulmonary metastases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00066-007-1724-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of single- and multi-isocenter planning with Dynamic WaveArc for multiple brain metastases.
J Radiat Res
December 2024
Department of Radiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.
Dynamic WaveArc (DWA) is a technique used for continuous, non-coplanar volumetric-modulated arc therapy on the Vero4DRT platform. This study aimed to evaluate the application of single-isocenter DWA (SI-DWA) for treating multiple brain metastases by comparing dose distribution and irradiation time with multi-isocenter DWA (MI-DWA) through retrospective treatment planning. Treatment plans were developed for SI-DWA and MI-DWA in 14 cases with 3-5 brain metastases.
View Article and Find Full Text PDFThe use of precision radiotherapy for the management of cancer related pain in the abdomen.
Curr Opin Support Palliat Care
December 2024
Cancer Research@UCC, School of Medicine and Health, University College Cork, Cork, Ireland.
Purpose Of Review: Abdominal pain due to cancer is a significant and debilitating symptom for cancer patients, which is commonly undertreated. Radiotherapy (RT) for the management of abdominal cancer pain is underused, with limited awareness of its benefit. This review presents a discussion on current precision RT options for the management of cancer pain in the abdomen.
View Article and Find Full Text PDFIncreased Dose in Spine Stereotactic Radiosurgery for Metastatic Disease: Are We Underestimating the Risks?
Medicina (Kaunas)
September 2024
Department of Neurological Surgery, Sheba Medical Center, Ramat Gan 5262000, Israel.
Article Synopsis
- The ESTRO guidelines suggest that treating spinal metastatic disease with doses ≤18 Gy is not recommended, emphasizing local control over potential complications.
- A study assessed patient outcomes from lower radiation doses, finding a 91.2% control rate with minimal complications (6%) in a cohort of 149 treatment sessions across 242 spinal levels.
- While higher doses may improve local control, the evidence for the strict guidelines is inadequate, indicating the need for individualized treatment plans based on patient circumstances and informed discussions about risks and benefits.
Feasibility, safety and preliminary efficacy of preoperative stereotactic radiotherapy on the future pancreatic neck transection margin to reduce the risk of pancreatic fistula after high-risk pancreatoduodenectomy (FIBROPANC): protocol for a multicentre, single-arm trial.
BMJ Open
September 2024
Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
Introduction: Postoperative pancreatic fistula (POPF) occurs in 25% of patients undergoing a high-risk pancreatoduodenectomy (PD) and is a driving cause of major morbidity, mortality, prolonged hospital stay and increased costs after PD. There is a need for perioperative methods to decrease these risks. In recent studies, preoperative chemoradiotherapy in patients with pancreatic ductal adenocarcinoma (PDAC) reduced the rate of POPF seemingly due to radiation-induced pancreatic fibrosis.
View Article and Find Full Text PDFPreoperative stereotactic radiosurgery for patients with 1-4 brain metastases: A single-arm phase 2 trial outcome analysis (NCT03398694).
Neurooncol Pract
October 2024
Department of Neurosurgery, University of Wisconsin Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Background: Stereotactic radiosurgery (SRS) following surgical resection is the standard of care for patients with symptomatic oligo brain metastasis (BM), however, it is associated with 10-15% local failure. Targeting a resection cavity is imprecise, thus preoperative radiosurgery where the target is well-defined may be superior, however, the efficacy of preoperative SRS has not yet been tested in a clinical trial.
Methods: We conducted a phase 2, single-arm trial of preoperative SRS followed by surgical resection in patients with 1-4 symptomatic oligo BMs (NCT03398694) with the primary objective of measuring 6-month local control (LC).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!